Literature DB >> 10226730

Vincristine revisited.

C E Gidding1, S J Kellie, W A Kamps, S S de Graaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10226730     DOI： 10.1016/s1040-8428(98)00023-7

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  66 in total

Review 1.  Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.

Authors:  Brad Moriyama; Stacey A Henning; Janice Leung; Oluwaseun Falade-Nwulia; Paul Jarosinski; Scott R Penzak; Thomas J Walsh
Journal:  Mycoses       Date:  2011-11-29       Impact factor: 4.377

2.  Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors.

Authors:  Zhao Yan; Zhong-ling Zhu; Zheng-zi Qian; Ge Hu; Hua-qing Wang; Wan-hui Liu; Guang Cheng
Journal:  Acta Pharmacol Sin       Date:  2012-06       Impact factor: 6.150

3.  Influence of blood-brain barrier efflux pumps on the distribution of vincristine in brain and brain tumors.

Authors:  Fan Wang; Feng Zhou; Gary D Kruh; James M Gallo
Journal:  Neuro Oncol       Date:  2010-05-25       Impact factor: 12.300

4.  MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma.

Authors:  Hanne Due; Anna Amanda Schönherz; Laura Ryø; Maria Nascimento Primo; Ditte Starberg Jespersen; Emil Aagaard Thomsen; Anne Stidholt Roug; Min Xiao; Xiaohong Tan; Yuyang Pang; Ken H Young; Martin Bøgsted; Jacob Giehm Mikkelsen; Karen Dybkær
Journal:  Blood Adv       Date:  2019-04-09

5.  A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine.

Authors:  H Tian; L Ip; H Luo; D C Chang; K Q Luo
Journal:  Br J Pharmacol       Date:  2007-01-18       Impact factor: 8.739

6.  Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.

Authors:  Surendra K Ravula; Min S Wang; Maxine A McClain; Seneshaw A Asress; Bruno Frazier; Jonathan D Glass
Journal:  Neurosci Lett       Date:  2007-01-10       Impact factor: 3.046

Review 7.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

8.  Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice.

Authors:  James W Behan; Vassilios I Avramis; Jason P Yun; Stan G Louie; Steven D Mittelman
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

9.  Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program.

Authors:  C Patrick Reynolds; Min H Kang; John M Maris; E Anders Kolb; Richard Gorlick; Jianrong Wu; Raushan T Kurmasheva; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2015-07-07       Impact factor: 3.167

Review 10.  The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.

Authors:  Mathias Gehrmann; Jürgen Radons; Michael Molls; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2008-02-05       Impact factor: 3.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.